Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNK | O75909 | 7/20 | 0.34 |
| ▸ | CDK9 | P50750 | 7/20 | 0.34 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4927742 | 0.88 | MAPT (0.34) | CCNKCDK9 | |
| SCHEMBL4923068 | 0.88 | LMNA (0.33) | CCNKCDK9 | |
| SCHEMBL4927106 | 0.84 | ALDH1A1 (0.42) | — | |
| Succinic Acid SCHEMBL2589228 | 0.82 | CCNK (0.36) | CCNKCDK9NPY5R | |
| SCHEMBL4919644 | 0.82 | RAB9A (0.35) | — | |
| SCHEMBL12175427 | 0.80 | CCNK (0.40) | CCNKCDK9NPY5R | |
| SCHEMBL13685572 | 0.79 | CLK4 (0.34) | CDK9 | |
| SCHEMBL13685707 | 0.79 | CLK4 (0.35) | — | |
| SCHEMBL4928912 | 0.75 | HRH3 (0.34) | — | |
| SCHEMBL4243300 | 0.74 | CCNT1 (0.38) | CDK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080269196-A1 | 6-Arylalkylamino-2,3,4,5-Tetrahydro-1H-Benzo[D]Azepines as 5-Ht2c Receptor Agonists | ELI LILLY AND COMPANY | 2008-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080269196-A1 | 6-Arylalkylamino-2,3,4,5-Tetrahydro-1H-Benzo[D]Azepines as 5-Ht2c Receptor Agonists | HTR2C, HTR1A, HTR2A | CCNK 3107/4885CDK9 3502/4885NPY5R 39/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.